Why the study?
Does intrathecal midazolam compared to fentanyl improve analgesic efficacy and safety in patients undergoing lower abdominal surgeries?
Does intrathecal midazolam compared to fentanyl improve analgesic efficacy and safety in patients undergoing lower abdominal surgeries?
Intrathecal midazolam is as effective as fentanyl as an additive to bupivacaine for prolonging analgesia in lower abdominal surgeries, but with fewer side effects.
Clinicians may prefer intrathecal midazolam to fentanyl in lower abdominal surgery; this RCT reinforces its role as a safer spinal adjuvant.
BACKGROUND prospective randomized double-blind study was designed to compare the analgesic efficacy and safety of intrathecal and fentanyl as an additive agent to bupivacaine for lower abdominal elective surgeries. patients classified in American Society of Anesthesiologists (ASA) classes I and II scheduled for lower abdominal were studied. Patients were randomly divided to receive either 12.5 mg hyperbaric bupivacaine plus 1mg midazolam (group BM, n=30) or 12.5 mg hyperbaric bupivacaine plus 25 μg fentanyl (group BF, n=30) intrathecal. time of onset and the duration of motor blockade were comparable among the groups while the time to sensory block was same in group BM and group BF. The duration of postoperative analgesia was similar in group BM and group . While it was same for group BM and BF. Symptoms of pruritus and vomiting was more in group BF. conclude that midazolam is as effective as fentanyl in prolonging the durations of both sensory block and analgesia with side effects.
No takes yet. Share an insight, caveat, or question.
Aasim et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: